Accounting Estimates Based on Assumptions Regarding the Impact of COVID-19
First written in FY2021-Q1. 6 of 11 entries say "Restated". Latest entry: FY2024-Q3.
The whole theme swung hardest in 2026: 5 of 22 companies on the "Worse" side.
103 other companies' latest entry also says "Restated".
- FY2024-Q3RestatedAnnual report
「Regarding the impact of COVID-19, the Company judges that its profit and loss position has improved as various restrictions have been eased and that conditions have come closer to those before the spread of the infection. The Company has made accounting estimates based on this assumption, and there have been no material changes from the assumptions underlying the estimates for the previous consolidated fiscal year.」
The Company indicates that its profit and loss position has improved as restrictions related to the infection have been eased and that conditions are approaching pre-pandemic levels. At the same time, it states that there have been no material changes to the assumptions underlying its accounting estimates. - FY2024-Q2RestatedAnnual report
「Regarding the impact of COVID-19, the Company Group forecasts that the impact will continue during the fiscal year ending February 2024, but that from the fiscal year ending February 2025 onward, conditions will recover to levels seen before the spread of the infection. The Company has made accounting estimates based on this assumption, and there have been no material changes from the assumptions underlying the estimates for the previous consolidated fiscal year. This assumption represents the Company's judgment as of the current date, and if future developments in the spread of the infection or its impact on the economic environment differ from the assumption, the Company's financial position, operating results and cash flows may be affected.」
The Company continues, without material changes, to use the accounting assumption that the impact of the infection will continue during the fiscal year ending February 2024, while conditions will recover to pre-pandemic levels from the fiscal year ending February 2025 onward. - FY2024-Q1Clarification of the timing of recoveryAnnual report
「Regarding the impact of COVID-19, the Company Group forecasts that the impact will continue during the fiscal year ending February 2024, but that from the fiscal year ending February 2025 onward, conditions will recover to levels seen before the spread of the infection. The Company has made accounting estimates based on this assumption, and there have been no material changes from the assumptions underlying the estimates for the previous consolidated fiscal year.」
The Company presents the accounting assumption in specific fiscal years: the impact of the infection will continue during the fiscal year ending February 2024, while conditions will recover to pre-pandemic levels from the fiscal year ending February 2025 onward. - FY2023Clarification of the recovery assumptionAnnual report
「The Company Group has made accounting estimates, including assessments of whether to recognize impairment losses, based on the assumption that a certain degree of impact from the spread of COVID-19 will remain at the beginning of the next consolidated fiscal year, while business performance will gradually recover due to factors including the downgrading of the infection's classification under the Infectious Diseases Act to Category 5.」
While a certain degree of impact will remain at the beginning of the next consolidated fiscal year, the Company has used in its accounting estimates the assumption that business performance will gradually recover due to factors including a change in the infection's legal classification. - FY2022Assumption that the impact of the infection will continueAnnual report
「Although it is difficult to predict when COVID-19 will subside or the extent of its impact, the Company has made accounting estimates based on the assumption that the impact of the spread of the infection will continue for at least a certain period.」
In addition to emphasizing the uncertainties noted in the previous year, the Company has used the assumption that the impact of the spread of the infection will continue for at least a certain period in its accounting estimates, including impairment assessments. - FY2022-Q3RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described in the additional information section of the annual securities report for the previous consolidated fiscal year.」
The Company continues to disclose that there have been no material changes to the assumptions underlying accounting estimates concerning the impact of COVID-19. - FY2022-Q2RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described in the additional information section of the annual securities report for the previous consolidated fiscal year.」
The Company continues to disclose that there have been no material changes to the assumptions underlying accounting estimates concerning the impact of the infection in the previous consolidated fiscal year. - FY2022-Q1RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described in the additional information section of the annual securities report for the previous consolidated fiscal year.」
The Company has disclosed that there have been no material changes to the assumptions underlying accounting estimates concerning the impact of the infection in the previous consolidated fiscal year. - FY2021SoftenedAnnual report
「The impact of the spread of COVID-19 involves many uncertainties, and changes in circumstances may affect accounting estimates from the next consolidated fiscal year onward.」
The Company no longer presents the previous assumption that demand will return to typical levels from the next period onward, instead emphasizing the uncertainty of the impact and its potential effect on future estimates. - FY2021-Q3RestatedAnnual report
「The Company has made accounting estimates, including assessments of the recoverability of deferred tax assets and whether to recognize impairment losses, based on the assumption that the impact of the spread of COVID-19 will not fully recover during the current period and that demand will return to typical levels from the next period onward.」
The Company continues to use the assumption that the impact of the infection will not fully recover during the current period and that demand will return to typical levels from the next period onward in assessing the recoverability of deferred tax assets and whether to recognize impairment losses. - FY2021-Q1First statedAnnual report
「The Company has made accounting estimates, including assessments of the recoverability of deferred tax assets and whether to recognize impairment losses, based on the assumption that the impact of the spread of COVID-19 will not fully recover during the current period and that demand will return to typical levels from the next period onward.」
The Company has reflected in its assessment of the recoverability of deferred tax assets and whether to recognize impairment losses the assumption that the impact of the infection will not fully recover during the current period and that demand will return to typical levels from the next period onward.